Physician profile
Paul E Johnson
NPI 1578539540
$1,528.39
in general payments reported to CMS, 2019-2025
12 companies · $52.52 in 2025
The $52.52 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $231 · 2022: $298 · 2023: $166 · 2024: $74.54 · 2025: $52.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $447.83 | 2019 | |
| Smith+Nephew, INC. | $271.69 | 2019-2022 | |
| Medtronic, INC. | $160.38 | 2022-2023 | Ligasure |
| Musculoskeletal Transplant Foundation INC. | $160.05 | 2020 | |
| Organogenesis INC. | $155.54 | 2022-2023 | Puraply |
| Next Science LLC | $94.26 | 2023 | Xperience, Surgx, Blastx |
| Medtronic Vascular, INC. | $65.51 | 2019 | |
| Solventum Corporation | $52.17 | 2024 | Prevena |
| Abbvie INC. | $48.01 | 2024-2025 | |
| Pfizer INC. | $26.88 | 2025 | |
| Aroa Biosurgery Incorporated | $24.58 | 2019 | |
| Salvin Dental Specialties, INC. | $21.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.